Primary Solitary Extragastrointestinal Stromal Tumor of the Greater Omentum Coexisting with Ulcerative Colitis

Overview

Journal Dig Dis Sci

Specialty Gastroenterology

Date 2006 Sep 13

PMID 16967314

Citations 5

Authors

Andreas M Kaiser

Jung-Cheng Kang

Andre R Tolazzi

Andy E Sherrod

Robert W Beart Jr

Affiliations

Soon will be listed here.

Citing Articles

Rectal gastrointestinal stromal tumor (GIST) in a patient with Crohn's disease: a rare coincidence case report and brief literature review.

Sadeghi A, Moghadam P, Mangeli F, Mohammadi M, Ghadirzadeh E, Rajabnia M Oxf Med Case Reports. 2024; 2024(5):omae039.

PMID: 38784781 PMC: 11110859. DOI: 10.1093/omcr/omae039.

Gastrointestinal Stromal Tumor (GIST) in Long-Standing Crohn's Disease on Anti-TNF Therapy.

Mendel D, Syed T, Lippman H, Davis B J Gastrointest Cancer. 2020; 52(1):332-335.

PMID: 32592037 DOI: 10.1007/s12029-020-00442-8.

Clinicopathological features and prognosis of omental gastrointestinal stromal tumor: evaluation of a pooled case series.

Feng F, Tian Y, Liu Z, Liu S, Xu G, Guo M Sci Rep. 2016; 6:30748.

PMID: 27471066 PMC: 4965821. DOI: 10.1038/srep30748.

Extra-gastrointestinal stromal tumor of the omentum: a rare case report and review of the literature.

Fagkrezos D, Touloumis Z, Giannila M, Penlidis C, Papaparaskeva K, Triantopoulou C Rare Tumors. 2012; 4(3):e44.

PMID: 23087800 PMC: 3475951. DOI: 10.4081/rt.2012.e44.

Extragastrointestinal stromal tumors of the omentum: review apropos of a case with a novel gain-of-function KIT mutation.

Dedemadi G, Georgoulis G, Kontopanos D, Anagnostou E, Morphopoulos G, Emile J J Gastrointest Cancer. 2009; 40(3-4):73-8.

PMID: 19894031 DOI: 10.1007/s12029-009-9089-4.

References

DeMatteo R, Lewis J, Leung D, Mudan S, Woodruff J, Brennan M . Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg. 2000; 231(1):51-8. PMC: 1420965. DOI: 10.1097/00000658-200001000-00008. View

Corless C . Assessing the prognosis of gastrointestinal stromal tumors: a growing role for molecular testing. Am J Clin Pathol. 2004; 122(1):11-3. DOI: 10.1309/MQ7Y-CGJL-AAFK-1Y0R. View

Miettinen M, Majidi M, Lasota J . Pathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs): a review. Eur J Cancer. 2003; 38 Suppl 5:S39-51. DOI: 10.1016/s0959-8049(02)80602-5. View

Demetri G, von Mehren M, Blanke C, Van Den Abbeele A, Eisenberg B, Roberts P . Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med. 2002; 347(7):472-80. DOI: 10.1056/NEJMoa020461. View

Kim C, Day S, Yeh K . Gastrointestinal stromal tumors: analysis of clinical and pathologic factors. Am Surg. 2001; 67(2):135-7. View

Verweij J, Casali P, Zalcberg J, Lecesne A, Reichardt P, Blay J . Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial. Lancet. 2004; 364(9440):1127-34. DOI: 10.1016/S0140-6736(04)17098-0. View

Koay M, Goh Y, Iacopetta B, Grieu F, Segal A, Sterrett G . Gastrointestinal stromal tumours (GISTs): a clinicopathological and molecular study of 66 cases. Pathology. 2005; 37(1):22-31. DOI: 10.1080/00313020400023628. View

Koh J, Trent J, Chen L, El-Naggar A, Hunt K, Pollock R . Gastrointestinal stromal tumors: overview of pathologic features, molecular biology, and therapy with imatinib mesylate. Histol Histopathol. 2004; 19(2):565-74. DOI: 10.14670/HH-19.565. View

Fletcher C, Berman J, Corless C, Gorstein F, Lasota J, Longley B . Diagnosis of gastrointestinal stromal tumors: a consensus approach. Int J Surg Pathol. 2002; 10(2):81-9. DOI: 10.1177/106689690201000201. View

10.

Kaiser A, Beart Jr R . Surgical management of ulcerative colitis. Swiss Med Wkly. 2001; 131(23-24):323-37. DOI: 10.4414/smw.2001.06134. View

11.

Sarlomo-Rikala M, Kovatich A, Barusevicius A, Miettinen M . CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34. Mod Pathol. 1998; 11(8):728-34. View

12.

Grieco A, Cavallaro A, Potenza A, Mule A, Tarquini E, Miele L . Gastrointestinal stromal tumor (GIST) and ulcerative colitis. J Exp Clin Cancer Res. 2003; 21(4):617-20. View

13.

Kim T, Lee H, Kang Y, Choe M, Ryu M, Chang H . Prognostic significance of c-kit mutation in localized gastrointestinal stromal tumors. Clin Cancer Res. 2004; 10(9):3076-81. DOI: 10.1158/1078-0432.ccr-03-0581. View

14.

Medeiros F, Corless C, Duensing A, Hornick J, Oliveira A, Heinrich M . KIT-negative gastrointestinal stromal tumors: proof of concept and therapeutic implications. Am J Surg Pathol. 2004; 28(7):889-94. DOI: 10.1097/00000478-200407000-00007. View

15.

Eisenberg B, Judson I . Surgery and imatinib in the management of GIST: emerging approaches to adjuvant and neoadjuvant therapy. Ann Surg Oncol. 2004; 11(5):465-75. DOI: 10.1245/ASO.2004.09.011. View

16.

Besana-Ciani I, Boni L, Dionigi G, Benevento A, Dionigi R . Outcome and long term results of surgical resection for gastrointestinal stromal tumors (GIST). Scand J Surg. 2003; 92(3):195-9. DOI: 10.1177/145749690309200304. View

17.

Takahashi T, Kuwao S, Yanagihara M, Kakita A . A primary solitary tumor of the lesser omentum with immunohistochemical features of gastrointestinal stromal tumors. Am J Gastroenterol. 1998; 93(11):2269-73. DOI: 10.1111/j.1572-0241.1998.00632.x. View

18.

Miettinen M, Monihan J, Sarlomo-Rikala M, Kovatich A, Carr N, Emory T . Gastrointestinal stromal tumors/smooth muscle tumors (GISTs) primary in the omentum and mesentery: clinicopathologic and immunohistochemical study of 26 cases. Am J Surg Pathol. 1999; 23(9):1109-18. DOI: 10.1097/00000478-199909000-00015. View